Skip to main content
Top
Metadata
Title
Intestinal microflora as a therapeutic target in inflammatory bowel disease
Authors
Keiichi Mitsuyama
Atsushi Toyonaga
Michio Sata
Publication date
01-01-2002
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue Special Issue 14/2002
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/BF03326418

Other articles of this Special Issue 14/2002

Journal of Gastroenterology 14/2002 Go to the issue

Gastroenterology and genetics—polymorphic gene and disease-caused gene

DNA methylation changes in gastrointestinal disease

Brain-gut relations, basics and clinics, from the viewpoint of neurogastroenterology

Brain-gut relation—what is neurogastroenterology?

Brain-gut relations, basics and clinics, from the viewpoint of neurogastroenterology

Acid-sensing pathways in rat gastrointestinal mucosa

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine